Niklas Mattson

This session focuses on accelerating the development of new therapies by emphasizing triple relationships with wholesalers, comparator sourcing and manufacturers.

By maintaining a strategic balance, pharma companies can enhance demand planning, streamline operations, and ensure trial success. 

 Key Takeaways: 

•  Strategic Balance: The importance of maintaining relationships with comparator sourcing, wholesalers and manufacturers for a stable supply chain. 
•  Enhance Transparency: Strategies on how to engage with manufacturers to address specific trial needs and improve demand planning. 
• Efficient Collaboration: Foster cooperation for streamlined operations and better availability of products for use in trial trials.